During the past decade, Institutul de Boli Cardiovasculare conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institutul de Boli Cardiovasculare" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Institutul de Boli Cardiovasculare" in a lesser frequency.

Most popular intervention types in "Institutul de Boli Cardiovasculare" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Beraprost Sodium Modified Release" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institutul de Boli Cardiovasculare" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institutul de Boli Cardiovasculare". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institutul de Boli Cardiovasculare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institutul de Boli Cardiovasculare, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".